Commonwealth Equity Services’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.76M Sell
9,588
-10,202
-52% -$2.93M ﹤0.01% 1752
2025
Q1
$6.1M Buy
19,790
+11,264
+132% +$3.47M 0.01% 1160
2024
Q4
$3.01M Buy
8,526
+301
+4% +$106K ﹤0.01% 1574
2024
Q3
$2.95M Buy
8,225
+1,374
+20% +$492K ﹤0.01% 1575
2024
Q2
$2.18M Buy
6,851
+1,959
+40% +$624K ﹤0.01% 1729
2024
Q1
$1.12M Sell
4,892
-374
-7% -$85.9K ﹤0.01% 2157
2023
Q4
$1.16M Buy
5,266
+67
+1% +$14.7K ﹤0.01% 2073
2023
Q3
$1.17M Sell
5,199
-32
-0.6% -$7.23K ﹤0.01% 1965
2023
Q2
$1.16M Sell
5,231
-130
-2% -$28.7K ﹤0.01% 1995
2023
Q1
$1.2K Buy
5,361
+299
+6% +$67 ﹤0.01% 1915
2022
Q4
$1.41M Sell
5,062
-38
-0.7% -$10.6K ﹤0.01% 1731
2022
Q3
$1.07M Buy
5,100
+256
+5% +$53.6K ﹤0.01% 1850
2022
Q2
$1.14M Buy
4,844
+227
+5% +$53.5K ﹤0.01% 1785
2022
Q1
$828K Sell
4,617
-57
-1% -$10.2K ﹤0.01% 2130
2021
Q4
$1.01M Buy
4,674
+44
+1% +$9.5K ﹤0.01% 1978
2021
Q3
$854K Buy
4,630
+40
+0.9% +$7.38K ﹤0.01% 2045
2021
Q2
$823K Sell
4,590
-35
-0.8% -$6.28K ﹤0.01% 2066
2021
Q1
$773K Sell
4,625
-194
-4% -$32.4K ﹤0.01% 1992
2020
Q4
$731K Sell
4,819
-1,470
-23% -$223K ﹤0.01% 1873
2020
Q3
$635K Buy
6,289
+3,477
+124% +$351K ﹤0.01% 1803
2020
Q2
$340K Sell
2,812
-80
-3% -$9.67K ﹤0.01% 2181
2020
Q1
$274K Sell
2,892
-252
-8% -$23.9K ﹤0.01% 2129
2019
Q4
$276K Buy
+3,144
New +$276K ﹤0.01% 2385
2017
Q4
Sell
-2,559
Closed -$300K 2720
2017
Q3
$300K Buy
2,559
+379
+17% +$44.4K ﹤0.01% 1975
2017
Q2
$283K Sell
2,180
-880
-29% -$114K ﹤0.01% 1955
2017
Q1
$414K Sell
3,060
-655
-18% -$88.6K ﹤0.01% 1632
2016
Q4
$533K Buy
3,715
+367
+11% +$52.7K ﹤0.01% 1373
2016
Q3
$395K Buy
3,348
+150
+5% +$17.7K ﹤0.01% 1526
2016
Q2
$339K Buy
+3,198
New +$339K ﹤0.01% 1587
2016
Q1
Sell
-1,490
Closed -$233K 2267
2015
Q4
$233K Sell
1,490
-1,336
-47% -$209K ﹤0.01% 1778
2015
Q3
$371K Buy
2,826
+453
+19% +$59.5K ﹤0.01% 1412
2015
Q2
$413K Buy
+2,373
New +$413K ﹤0.01% 1450
2014
Q2
Sell
-10,560
Closed -$993K 2103
2014
Q1
$993K Buy
10,560
+190
+2% +$17.9K 0.01% 804
2013
Q4
$1.17M Buy
10,370
+1,317
+15% +$149K 0.02% 684
2013
Q3
$714K Buy
+9,053
New +$714K 0.01% 896